Company intelligence / Profile preview

Qingdao MDBio

Qingdao, Shandong, China

Ownership: Private
Development stage: Other

Overview

Qingdao MDBio Biotech Co., Ltd. (officially registered as Qingdao Shenggong Biotechnology Co., Ltd.) is a life sciences company established in 2002 in Qingdao, China. It operates as a subsidiary of MDBio, Inc. (Taiwan), a major provider of biological reagents and services. Qingdao MDBio specializes in the development, manufacture, and sale of molecular biology reagents, PCR-related products, ELISA kits, biochemical consumables, and laboratory instruments. Additionally, the company offers professional technical services, including DNA sequencing, primer synthesis, and bioinformatics software development, supporting academic, clinical, and industrial research.

Industry: Drug Discovery Services

Beyond the preview

Go deeper on Qingdao MDBio.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Qingdao MDBio.

Explore the full profile